On July 2nd, 2025, Blueprint Biomed had the opportunity to pitch at Chiotec in Aachen, a premier biotech and innovation event. This year, Chiotec took place alongside the CHIO, an international horse show attracting a global audience of investors, industry leaders, and startup ecosystem stakeholders.

Out of numerous applicants, Blueprint Biomed was selected as one of only 10 teams to participate in the pitch battle. With just two minutes to present, the team shared its vision and demonstrated the potential impact of its work to a large and diverse audience.

Blueprint Biomed was awarded 3rd Prize – the Accelerator Prize, sponsored by b.value AG, an initiative supporting startups in translating innovations from lab to market. This recognition will enable the company to further advance its technology, expand its network, and engage with key players in regenerative medicine.

Participation in Chiotec offered valuable exposure, feedback, and inspiration from other pioneering startups. We look forward to leveraging this momentum as it continues its journey from research to market-ready solutions.

Photo credits: Chiotec